Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is mucosal melanoma?
Mucosal melanoma is a rare and aggressive form of melanoma that arises from pigment cells (melanocytes) located not in the skin but in the mucous membranes — the moist inner linings of the body. The most common sites are the lining of the nose and sinuses (sinonasal), the mouth and throat, and the anorectal region, with the female genital tract (vulva and vagina) and other linings also affected. Unlike skin melanoma, it is not caused by sun exposure, and it has a different genetic profile — it less often carries the BRAF mutation common in skin melanoma and more often carries changes in the KIT gene. Because these tumors grow in hidden, hard-to-see places, they tend to be found late, after symptoms like nosebleeds, a dark spot in the mouth, or rectal bleeding appear. Complete surgical removal is the main treatment and the best chance at cure, but the locations make wide margins difficult, so radiation is frequently added to improve local control. When the disease spreads, immunotherapy is the foundation of treatment, with KIT-targeted pills for the subset whose tumors carry that change.
The main types
Doctors group mucosal melanoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Head and neck mucosal melanoma (sinonasal and oral) | The most common group, arising in the lining of the nose, sinuses, mouth, or throat; often causes nosebleeds, nasal blockage, or a dark spot in the mouth. |
| Anorectal mucosal melanoma | Arises in the lining of the anus or rectum; frequently mistaken for hemorrhoids at first because it causes bleeding, and often found late. |
| Genital (vulvovaginal) and other mucosal melanoma | Arises in the lining of the vulva, vagina, or other mucosal surfaces; managed with surgery and radiation tailored to the site, plus systemic therapy if it spreads. |
Staging, in plain terms
Mucosal melanoma is staged according to where it arises. Sinonasal mucosal melanoma has its own head-and-neck staging system that starts at a relatively advanced stage because even small tumors here behave aggressively. Other sites use staging adapted to their location. Across all sites the key questions are whether the tumor can be completely removed and whether it has spread to lymph nodes or distant organs.
| Site-specific staging (sinonasal mucosal melanoma uses its own head-and-neck TNM) | What it generally means |
|---|---|
| Localized | Tumor confined to its site of origin. Treated with complete surgical removal, often followed by radiation to improve local control. |
| Regional | Spread to nearby lymph nodes. Managed with surgery and radiation to the area, often with systemic therapy. |
| Metastatic | Spread to distant organs such as the lungs, liver, or brain. Treated mainly with immunotherapy, and with KIT-targeted drugs when the tumor carries a KIT change. |
The standard of care
Mucosal Melanoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the main treatment)
Complete removal of the tumor offers the best chance of cure. Because of the cramped, delicate locations, achieving wide margins is hard, so surgery is often combined with radiation.
Radiation after surgery
Radiation to the tumor site improves local control when wide margins are not possible — a common situation in the nose, sinuses, and other confined areas — and is sometimes used as the main local treatment when surgery would be too disfiguring.
Immunotherapy for advanced disease
Immune-checkpoint drugs are the foundation of treatment when the cancer has spread; response rates are lower than in skin melanoma but still meaningful, and combinations are used in selected patients.
KIT-targeted therapy (selected tumors)
Tumors that carry a KIT gene change — more common in mucosal melanoma — can respond to KIT-blocking pills, so molecular testing is part of the work-up.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. Melanoma is relatively resistant to ordinary radiation, but in mucosal melanoma radiation still plays an important role because the tumor's hidden, cramped locations make wide surgical margins difficult. Radiation to the tumor site after surgery lowers the chance of local recurrence, and for sinonasal tumors near the eyes and brain, high-dose particle beams (proton or carbon-ion) at specialized centers can concentrate the dose on the tumor while sparing those delicate structures. Radiation is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.
The main ways radiation is delivered for mucosal melanoma:
Surgery
Complete removal of the tumor is the primary, potentially curative treatment, though the confined locations often limit how wide a margin can be taken.
External-beam / particle radiation
Radiation to the tumor site improves local control after surgery; for sinonasal tumors near the eyes and brain, particle-beam radiation (proton or carbon-ion) at specialized centers can deliver a high dose while sparing those structures.
Definitive radiation (when surgery is too disfiguring)
When removing the tumor would cost vital function or appearance, radiation can serve as the main local treatment, sometimes alongside systemic therapy.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiation improves local control: Series of sinonasal and other mucosal melanomas show that adding radiation after surgery reduces local recurrence, supporting its routine use where wide margins cannot be achieved, even though it does not replace the need for surgery.[1]
Head-and-neck mucosal melanoma studies (2020–2025)
Immunotherapy in a distinct disease: Pooled analyses confirm that immune-checkpoint drugs help patients with advanced mucosal melanoma, though responses are less frequent than in skin melanoma, prompting trials of combinations tailored to this subtype.[2]
Melanoma immunotherapy analyses (2021–2025)
Targeting KIT in mucosal melanoma: Because mucosal melanomas more often carry KIT gene changes than skin melanomas do, molecular testing can identify patients who benefit from KIT-blocking pills, and research continues into improving and prolonging these responses.[3]
Molecular melanoma treatment studies (2020–2024)
Common questions
Did the sun cause this melanoma? No. Mucosal melanoma starts on the moist inner linings of the body — like the nose, mouth, or anorectal area — which are not exposed to the sun. Unlike skin melanoma, it is not caused by ultraviolet light, and it has a different genetic make-up.
Why is radiation used if melanoma resists it? Melanoma is relatively radiation-resistant, but in mucosal melanoma the tumor sits in tight spaces where surgeons often cannot remove a wide margin of healthy tissue. Radiation to the area after surgery helps control any cells left behind, lowering the chance the cancer returns locally.
Should my tumor be tested for gene changes? Yes. Mucosal melanomas more often carry a KIT gene change than skin melanomas do. If testing finds one, KIT-blocking pills may be an option, especially for advanced disease — so molecular testing is a standard part of the work-up.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.